Pliant Therapeutics, Inc. (PLRX) income statement
PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.60−0.02 (-4.02%)
Close on Nov 20, 2026Market cap $36.85MP/E –Yield 0.00%
Pliant Therapeutics, Inc. financial ratios
See a number that looks wrong?